The decision is a setback for GLP-1 drugmakers, though it's not entirely surprising given the Trump administration’s focus on curbing government spending.
Trump rejects Biden administration plan to let Medicare cover obesity drugs
1 month ago
27
Bengali (Bangladesh) · 
English (United States) ·